LK 204–545, a highly selective β1-adrenoceptor antagonist at human β-adrenoceptors
- 19 February 1999
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 367 (2-3) , 431-435
- https://doi.org/10.1016/s0014-2999(99)00019-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Site‐directed mutagenesis of the human β3‐adrenoceptorEuropean Journal of Biochemistry, 1998
- Mediation of most atypical effects by species homologues of the β3‐adrenoceptorBritish Journal of Pharmacology, 1994
- Partial Agonist Activity of CeliprololJournal of Cardiovascular Pharmacology, 1993
- BRL 35135, a potent and selective atypical β-adrenoceptor agonistThe American Journal of Clinical Nutrition, 1992
- CGP 20712 A: a useful tool for quantitating β1- and β2-adrenoceptorsEuropean Journal of Pharmacology, 1986
- Characterization of beta-adrenoceptor subtypes in rat kidney with new highly selective β1 blockers and their role in renin releaseBiochemical Pharmacology, 1985
- A practical computer-based approach to the analysis of radioligand binding experimentsComputer Programs in Biomedicine, 1983
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980
- How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?Journal of Pharmacy and Pharmacology, 1978
- A Rapid Enzymatic Assay for GlycerolNature, 1962